Get started
Author

Terry Barrett

Identification and Optimization of Anthranilic Sulfonamides as Novel, Selective Cholecystokinin-2 Receptor Antagonists
2006 · Brett D. Allison, Victor K. Phuong, et al. · Journal of Medicinal Chemistry · 36
#388 IONIS-FB-LRx, an antisense oligonucleotide to complement factor B for treatment of IgA nephropathy
2024 · Michelle Hladunewich, Sean Barbour, et al. · Nephrology Dialysis Transplantation · 9
Evaluation of the novel TMPRSS6 antisense inhibitor sapablursen for treatment of polycythemia vera: Results of the imprssion clinical trial
2025 · Jeanne Palmer, Jonathan How, et al. · Blood · 5
An Exploratory Trial of an Investigational RNA Therapeutic, IONIS-FB-LRx, for Treatment of IgA Nephropathy
2022 · Sean Barbour, Michelle A. Hladunewich, et al. · Journal of the American Society of Nephrology · 4
Phase II Results of an Investigational RNA Therapeutic to Complement Factor B, IONIS-FB-LRx, for Treatment of IgA Nephropathy
2024 · Sean Barbour, Michelle A. Hladunewich, et al. · Journal of the American Society of Nephrology · 3
Therapeutic effects of Tmprss6 suppression are negated by iron overload in a mouse model of beta-thalassemia
2025 · Vida Zhang, Terry Barrett, et al. · Blood
PDF
#3089 Suppression of complement alternative pathway by monthly dosing of sefaxersen, a novel antisense oligonucleotide therapy in development for IgAN
2025 · Jeannette Lo, Nelson Guerreiro, et al. · Nephrology Dialysis Transplantation
PDF
Defense against Reactive Oxygen Species during Gastric Wound Repair is Mediated by the Cystine‐Glutamate xCT Transporter in Response to Injury
2019 · Emma L Teal, Jayati L Chakrabarti, et al. · The FASEB Journal
Works count: 8
Citation count: 57
H-index: 4
I10-index: 1
Year
Topic
Type